Demystifying Macrogenics: Insights From 14 Analyst Reviews
Demystifying Macrogenics: Insights From 14 Analyst Reviews
揭开宏观经济的神秘面纱：来自14条分析师评论的见解
Analysts' ratings for Macrogenics (NASDAQ:MGNX) over the last quarter vary from bullish to bearish, as provided by 14 analysts.
14位分析师提供的分析师对Macrogenics（纳斯达克股票代码：MGNX）在上个季度的评级从看涨到看跌不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Macrogenics, presenting an average target of $17.57, a high estimate of $29.00, and a low estimate of $4.00. Highlighting a 7.18% decrease, the current average has fallen from the previous average price target of $18.93.
在对12个月目标股价的评估中，分析师公布了对Macrogenics的见解，将平均目标价定为17.57美元，最高估计为29.00美元，低估值为4.00美元。当前的平均价格已低于之前的平均目标价18.93美元，跌幅为7.18％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The standing of Macrogenics among financial...
通过对分析师...
登录免费看全文
登录/注册